{"component": "clause", "props": {"groups": [{"size": 2, "samples": [{"hash": "3HYhYy6mQkC", "uri": "/contracts/3HYhYy6mQkC#third-party-challenges", "label": "Cost Sharing Agreement", "score": 28.271463994, "published": true}], "snippet": "Each Party shall bear its own attorneys\u2019 fees and costs in the defense of any third-party action or proceeding to attack, set aside, void or annul any action by the City on the Annexation, or any of the proceedings, acts or determinations taken, done or made prior to or concurrently with the Annexation.", "snippet_links": [{"key": "each-party", "type": "clause", "offset": [0, 10]}, {"key": "fees-and-costs", "type": "definition", "offset": [41, 55]}, {"key": "action-or-proceeding", "type": "clause", "offset": [90, 110]}, {"key": "set-aside", "type": "clause", "offset": [122, 131]}, {"key": "action-by-the-city", "type": "clause", "offset": [151, 169]}, {"key": "the-proceedings", "type": "clause", "offset": [199, 214]}, {"key": "prior-to-or-concurrently-with-the", "type": "clause", "offset": [259, 292]}], "hash": "5cc3498bbe40cd5c004d3f0d13ab2638", "id": 7}, {"size": 3, "samples": [{"hash": "dqx1nA5AtKY", "uri": "/contracts/dqx1nA5AtKY#third-party-challenges", "label": "License and Collaboration Agreement (Landos Biopharma, Inc.)", "score": 32.5728952772, "published": true}, {"hash": "2tL392lDiYZ", "uri": "/contracts/2tL392lDiYZ#third-party-challenges", "label": "License and Collaboration Agreement (LianBio)", "score": 32.4880219028, "published": true}], "snippet": "There are no claims, judgments, or settlements against, or amounts with respect thereto, made against Landos or any of its Affiliates relating to the Licensed Patent Rights or the Licensed Know-How, and no written claim or litigation has been received by Landos or its Affiliates or, [***], threatened by any Person (i) alleging that the Licensed Patent Rights are invalid or unenforceable, (ii) asserting the misuse of any of the Licensed Patent Rights, (iii) challenging Landos\u2019 Control of the Licensed Patent Rights (i.e., alleging that a Third Party has a right or interest in or to the Licensed Technology), or (iv) alleging misappropriation of the Know-How of any Third Party used in the Development, Manufacture or Commercialization of Licensed Products by or on behalf of Landos prior to the Effective Date.", "snippet_links": [{"key": "no-claims", "type": "clause", "offset": [10, 19]}, {"key": "relating-to", "type": "definition", "offset": [134, 145]}, {"key": "licensed-patent-rights", "type": "clause", "offset": [150, 172]}, {"key": "licensed-know", "type": "definition", "offset": [180, 193]}, {"key": "claim-or-litigation", "type": "clause", "offset": [214, 233]}, {"key": "received-by", "type": "definition", "offset": [243, 254]}, {"key": "any-person", "type": "definition", "offset": [305, 315]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [365, 389]}, {"key": "control-of-the", "type": "clause", "offset": [481, 495]}, {"key": "a-third-party", "type": "clause", "offset": [540, 553]}, {"key": "licensed-technology", "type": "clause", "offset": [591, 610]}, {"key": "the-development", "type": "clause", "offset": [690, 705]}, {"key": "commercialization-of-licensed-products", "type": "clause", "offset": [722, 760]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [761, 779]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [787, 814]}], "hash": "22c04cd45f7d4ad82b4da6c1e429db2c", "id": 1}, {"size": 3, "samples": [{"hash": "4ijHOSIe6Bk", "uri": "/contracts/4ijHOSIe6Bk#third-party-challenges", "label": "Settlement Agreement", "score": 33.7275451901, "published": true}, {"hash": "ciTHFWVsSXE", "uri": "/contracts/ciTHFWVsSXE#third-party-challenges", "label": "Settlement Agreement", "score": 33.5181426103, "published": true}], "snippet": "The Parties shall promptly notify each other of any judicial or administrative challenge to this Agreement or any portion thereof, and shall defend against any challenge to the Agreement.", "snippet_links": [{"key": "the-parties-shall", "type": "clause", "offset": [0, 17]}, {"key": "promptly-notify", "type": "clause", "offset": [18, 33]}, {"key": "agreement-or", "type": "definition", "offset": [97, 109]}, {"key": "the-agreement", "type": "clause", "offset": [173, 186]}], "hash": "8237c4573fdcae1523eb824e7925b34a", "id": 2}, {"size": 2, "samples": [{"hash": "l4tCKLcxjU8", "uri": "/contracts/l4tCKLcxjU8#third-party-challenges", "label": "Product Development and Commercialization Agreement (Pozen Inc /Nc)", "score": 21.0, "published": true}, {"hash": "9VwnhjIGxU8", "uri": "/contracts/9VwnhjIGxU8#third-party-challenges", "label": "Product Development and Commercialization Agreement (Pozen Inc /Nc)", "score": 21.0, "published": true}], "snippet": "If a POZEN Patent becomes the subject of any proceeding commenced by a Third Party in connection with an opposition, reexamination request, action for declaratory judgment, nullity action, interference or other attack upon the validity, title or enforceability thereof, then GSK will have the primary right, but not the obligation, to control such defense at its sole cost. GSK will permit POZEN to participate in the proceeding to the extent permissible under law, and to be represented by its own counsel in such proceeding at its expense. If GSK elects not to defend against such action, it will notify POZEN thereof in writing without delay and not less than 30 days prior to any deadline for the initial response or other initial filing in any such proceeding, and POZEN will then have the right to assume defense of such Third Party action at its own expense. If POZEN controls such action, it will not enter into any settlement or other voluntary final disposition of a defense under this Section 8.5 relating to a POZEN Patent if the rights and privileges of GSK under this Agreement would be materially impaired thereby without the prior consent of GSK, such consent not to be unreasonably withheld or delayed. If GSK controls such action, it will not enter into any settlement or other voluntary final disposition of a defense under this Section 8.5 relating to a POZEN Patent without the prior written consent of POZEN, such consent not to be unreasonably withheld or delayed. The control of any enforcement proceeding brought in connection with a Third-Party challenge and the allocation of any recovery arising from such an enforcement action will be subject to Section 8.4(d).", "snippet_links": [{"key": "subject-of", "type": "clause", "offset": [30, 40]}, {"key": "by-a-third-party", "type": "clause", "offset": [66, 82]}, {"key": "in-connection-with", "type": "clause", "offset": [83, 101]}, {"key": "declaratory-judgment", "type": "definition", "offset": [151, 171]}, {"key": "primary-right", "type": "definition", "offset": [293, 306]}, {"key": "the-obligation", "type": "clause", "offset": [316, 330]}, {"key": "to-control", "type": "definition", "offset": [332, 342]}, {"key": "participate-in", "type": "definition", "offset": [399, 413]}, {"key": "to-the-extent", "type": "clause", "offset": [429, 442]}, {"key": "represented-by", "type": "definition", "offset": [476, 490]}, {"key": "own-counsel", "type": "clause", "offset": [495, 506]}, {"key": "in-writing", "type": "clause", "offset": [620, 630]}, {"key": "without-delay", "type": "definition", "offset": [631, 644]}, {"key": "prior-to", "type": "definition", "offset": [671, 679]}, {"key": "initial-response", "type": "definition", "offset": [701, 717]}, {"key": "initial-filing", "type": "definition", "offset": [727, 741]}, {"key": "right-to-assume-defense", "type": "clause", "offset": [795, 818]}, {"key": "third-party-action", "type": "clause", "offset": [827, 845]}, {"key": "any-settlement", "type": "clause", "offset": [920, 934]}, {"key": "disposition-of", "type": "clause", "offset": [960, 974]}, {"key": "section-85", "type": "clause", "offset": [996, 1007]}, {"key": "relating-to", "type": "definition", "offset": [1008, 1019]}, {"key": "rights-and-privileges", "type": "definition", "offset": [1042, 1063]}, {"key": "this-agreement", "type": "clause", "offset": [1077, 1091]}, {"key": "consent-of", "type": "clause", "offset": [1147, 1157]}, {"key": "consent-not-to-be-unreasonably-withheld", "type": "clause", "offset": [1168, 1207]}, {"key": "prior-written-consent", "type": "clause", "offset": [1399, 1420]}, {"key": "control-of", "type": "definition", "offset": [1492, 1502]}, {"key": "enforcement-proceeding", "type": "definition", "offset": [1507, 1529]}, {"key": "allocation-of", "type": "clause", "offset": [1589, 1602]}, {"key": "enforcement-action", "type": "clause", "offset": [1637, 1655]}, {"key": "subject-to-section", "type": "clause", "offset": [1664, 1682]}], "hash": "77922cb6f1720844a47b19a2d9335f61", "id": 3}, {"size": 2, "samples": [{"hash": "jgq6QxC8gvV", "uri": "/contracts/jgq6QxC8gvV#third-party-challenges", "label": "License Agreement (Coherus BioSciences, Inc.)", "score": 35.2012320329, "published": true}, {"hash": "48OH0wF4opz", "uri": "/contracts/48OH0wF4opz#third-party-challenges", "label": "License Agreement (Surface Oncology, Inc.)", "score": 31.9596167009, "published": true}], "snippet": "There are no claims, judgments, or settlements against, or amounts with respect thereto, made against Surface or any of its Affiliates relating to the Licensed Patents or the Licensed Know-How. No claim or litigation has been received by Surface or its Affiliates or, to Surface\u2019s knowledge, threatened by any Person (i) alleging that the Licensed Patents are invalid or unenforceable, (ii) challenging Surface\u2019s Control of the Licensed Technology (i.e., alleging that a Third Party has a right or interest in or to the Licensed Technology) or (iii) alleging misappropriation of the Know-How of any Third Party used in the Development, Manufacture or Commercialization of Licensed Antibodies or Licensed Products by or on behalf of Surface prior to the Effective Date.", "snippet_links": [{"key": "no-claims", "type": "clause", "offset": [10, 19]}, {"key": "relating-to", "type": "definition", "offset": [135, 146]}, {"key": "licensed-patents", "type": "clause", "offset": [151, 167]}, {"key": "licensed-know", "type": "definition", "offset": [175, 188]}, {"key": "claim-or-litigation", "type": "clause", "offset": [197, 216]}, {"key": "received-by", "type": "definition", "offset": [226, 237]}, {"key": "any-person", "type": "definition", "offset": [306, 316]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [360, 384]}, {"key": "control-of-the", "type": "clause", "offset": [413, 427]}, {"key": "licensed-technology", "type": "clause", "offset": [428, 447]}, {"key": "a-third-party", "type": "clause", "offset": [469, 482]}, {"key": "the-development", "type": "clause", "offset": [619, 634]}, {"key": "licensed-antibodies", "type": "clause", "offset": [672, 691]}, {"key": "licensed-products", "type": "clause", "offset": [695, 712]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [713, 731]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [740, 767]}], "hash": "6ea7423fdce2aefb2a8c71fd948975de", "id": 4}, {"size": 2, "samples": [{"hash": "957F4wASNpd", "uri": "/contracts/957F4wASNpd#third-party-challenges", "label": "License and Collaboration Agreement (Lyra Therapeutics, Inc.)", "score": 32.6030116359, "published": true}, {"hash": "e0tNINvM4QN", "uri": "/contracts/e0tNINvM4QN#third-party-challenges", "label": "License and Collaboration Agreement (LianBio)", "score": 32.4880219028, "published": true}], "snippet": "There are no claims, judgments, or settlements against, or amounts with respect thereto, made against Lyra or any of its Affiliates relating to the Licensed Patent Rights or the Licensed Know-How, and no claim or litigation has been received by Lyra or its Affiliates or, to Lyra\u2019s knowledge, threatened by any Person (i) alleging that the Licensed Patent Rights are invalid or unenforceable, (ii) asserting the misuse of any of the Licensed Patent Rights, (iii) challenging Lyra\u2019s Control of the Licensed Patent Rights (i.e., alleging that a Third Party has a right or interest in or to the Licensed Technology), or (iv) alleging misappropriation of the Know-How of any Third Party used in the Development, Manufacture or Commercialization of Licensed Products by or on behalf of Lyra prior to the Effective Date.", "snippet_links": [{"key": "no-claims", "type": "clause", "offset": [10, 19]}, {"key": "relating-to", "type": "definition", "offset": [132, 143]}, {"key": "licensed-patent-rights", "type": "clause", "offset": [148, 170]}, {"key": "licensed-know", "type": "definition", "offset": [178, 191]}, {"key": "claim-or-litigation", "type": "clause", "offset": [204, 223]}, {"key": "received-by", "type": "definition", "offset": [233, 244]}, {"key": "any-person", "type": "definition", "offset": [307, 317]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [367, 391]}, {"key": "control-of-the", "type": "clause", "offset": [482, 496]}, {"key": "a-third-party", "type": "clause", "offset": [541, 554]}, {"key": "licensed-technology", "type": "clause", "offset": [592, 611]}, {"key": "the-development", "type": "clause", "offset": [691, 706]}, {"key": "commercialization-of-licensed-products", "type": "clause", "offset": [723, 761]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [762, 780]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [786, 813]}], "hash": "41d3a524a1c9c105d7ac436ff2f1486c", "id": 5}, {"size": 2, "samples": [{"hash": "lTdtVvpKZlf", "uri": "/contracts/lTdtVvpKZlf#third-party-challenges", "label": "Exclusive License Agreement (LianBio)", "score": 32.4880219028, "published": true}], "snippet": "There are no claims, judgments, or settlements against, or amounts with respect thereto, made against Company or any of its Affiliates relating to the Licensed Patents or the Licensed Know-How. [***], [***], no claim or litigation has been received by Company or its Affiliates or, [***], threatened by any Person (i) alleging that the Licensed Patents are invalid or unenforceable, (ii) asserting the misuse of any of the Licensed Patents, (iii) challenging Company\u2019s Control of the Licensed Patents (i.e., alleging that a Third Party has a right or interest in or to the Licensed Technology) or (iv) alleging misappropriation of the Know-How of any Third Party used in the Development, Manufacture or Commercialization of Licensed Products by or on behalf of Company prior to the Effective Date.", "snippet_links": [{"key": "no-claims", "type": "clause", "offset": [10, 19]}, {"key": "relating-to", "type": "definition", "offset": [135, 146]}, {"key": "licensed-patents", "type": "clause", "offset": [151, 167]}, {"key": "licensed-know", "type": "definition", "offset": [175, 188]}, {"key": "claim-or-litigation", "type": "clause", "offset": [211, 230]}, {"key": "by-company", "type": "clause", "offset": [249, 259]}, {"key": "any-person", "type": "definition", "offset": [303, 313]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [357, 381]}, {"key": "control-of-the", "type": "clause", "offset": [469, 483]}, {"key": "a-third-party", "type": "clause", "offset": [522, 535]}, {"key": "licensed-technology", "type": "clause", "offset": [573, 592]}, {"key": "the-development", "type": "clause", "offset": [671, 686]}, {"key": "commercialization-of-licensed-products", "type": "clause", "offset": [703, 741]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [742, 760]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [769, 796]}], "hash": "826c2cb57b62938a30b58542917791b3", "id": 6}, {"size": 1, "samples": [{"hash": "3GrZsIqdO1e", "uri": "/contracts/3GrZsIqdO1e#third-party-challenges", "label": "License Agreement (Blueprint Medicines Corp)", "score": 30.8425735797, "published": true}], "snippet": "There are no claims, judgments, or settlements against, or amounts with respect thereto, made against Blueprint or any of its Affiliates relating to the Licensed Technology. No claim or litigation has been brought or, to Blueprint\u2019s knowledge, threatened by any Person (a) alleging that the Licensed Patents are invalid or unenforceable, (b) asserting the misuse, or non-infringement of any of the Licensed Patents, (c) regarding inventorship of or challenging Blueprint\u2019s Control of the Licensed Patents or (d) alleging misappropriation of the Know-How used in the Development or Manufacture of Licensed Products by or on behalf of Blueprint prior to the Effective Date.", "snippet_links": [{"key": "no-claims", "type": "clause", "offset": [10, 19]}, {"key": "relating-to", "type": "definition", "offset": [137, 148]}, {"key": "licensed-technology", "type": "clause", "offset": [153, 172]}, {"key": "claim-or-litigation", "type": "clause", "offset": [177, 196]}, {"key": "any-person", "type": "definition", "offset": [258, 268]}, {"key": "licensed-patents", "type": "clause", "offset": [291, 307]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [312, 336]}, {"key": "infringement-of", "type": "clause", "offset": [371, 386]}, {"key": "control-of-the", "type": "clause", "offset": [473, 487]}, {"key": "the-development", "type": "clause", "offset": [562, 577]}, {"key": "manufacture-of-licensed-products", "type": "clause", "offset": [581, 613]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [614, 632]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [643, 670]}], "hash": "9f441b16b41fca27065b55c4db31dbd4", "id": 8}, {"size": 1, "samples": [{"hash": "a1yV7OLTX4z", "uri": "/contracts/a1yV7OLTX4z#third-party-challenges", "label": "Franchise Agreement (Cohesant Inc.)", "score": 21.0, "published": true}], "snippet": "You agree to notify us promptly of any unauthorized use of the Marks that you suspect or of which you have knowledge. You also agree to inform us promptly of any challenge by any person or entity to the validity of our ownership of or our right to license others to use any of the Marks. You acknowledge and agree that we have the right, but not the obligation, to initiate, direct and control any litigation or administrative proceeding relating to the Marks, including, but not limited to, any settlement. You agree to sign all documents and, render any other assistance we may deem necessary to the defense or prosecution of any such proceeding.", "snippet_links": [{"key": "you-agree-to", "type": "clause", "offset": [0, 12]}, {"key": "notify-us", "type": "clause", "offset": [13, 22]}, {"key": "use-of-the-marks", "type": "clause", "offset": [52, 68]}, {"key": "have-knowledge", "type": "definition", "offset": [102, 116]}, {"key": "person-or-entity", "type": "definition", "offset": [179, 195]}, {"key": "ownership-of", "type": "clause", "offset": [219, 231]}, {"key": "right-to-license", "type": "clause", "offset": [239, 255]}, {"key": "you-acknowledge-and-agree-that", "type": "clause", "offset": [288, 318]}, {"key": "the-right", "type": "clause", "offset": [327, 336]}, {"key": "the-obligation", "type": "clause", "offset": [346, 360]}, {"key": "litigation-or-administrative-proceeding", "type": "clause", "offset": [398, 437]}, {"key": "relating-to", "type": "definition", "offset": [438, 449]}, {"key": "not-limited", "type": "clause", "offset": [476, 487]}, {"key": "any-settlement", "type": "clause", "offset": [492, 506]}, {"key": "all-documents", "type": "definition", "offset": [526, 539]}, {"key": "other-assistance", "type": "definition", "offset": [556, 572]}], "hash": "419d1a0966608816ed771fe2be356033", "id": 9}, {"size": 1, "samples": [{"hash": "kZ8cBkICLxD", "uri": "/contracts/kZ8cBkICLxD#third-party-challenges", "label": "Option and License Agreement (Sutro Biopharma, Inc.)", "score": 33.1587953457, "published": true}], "snippet": "There are no claims, judgments, or settlements against, or amounts with respect thereto, made or, to Sutro\u2019s knowledge, threatened by any Person against Sutro or any of its Affiliates relating to the Licensed Patents or the Licensed Know-How. No claim or notice of proceeding has been received by Sutro or its Affiliates or, to Sutro\u2019s knowledge, threatened by any Person (i) alleging that the Licensed Patents are invalid or unenforceable, (ii) asserting the misuse of any of the Licensed Patents, (iii) challenging Sutro\u2019s Control of the Licensed Patents (i.e., alleging that a Third Party has a right or interest in or to the Licensed Technology) or (iv) alleging misappropriation of the Know-How of any Third Party used in the Development, Manufacture or Commercialization of the Licensed Compound or Licensed Products by or on behalf of Sutro prior to the Effective Date.", "snippet_links": [{"key": "no-claims", "type": "clause", "offset": [10, 19]}, {"key": "any-person", "type": "definition", "offset": [134, 144]}, {"key": "relating-to", "type": "definition", "offset": [184, 195]}, {"key": "licensed-patents", "type": "clause", "offset": [200, 216]}, {"key": "licensed-know", "type": "definition", "offset": [224, 237]}, {"key": "notice-of-proceeding", "type": "clause", "offset": [255, 275]}, {"key": "received-by", "type": "definition", "offset": [285, 296]}, {"key": "invalid-or-unenforceable", "type": "clause", "offset": [415, 439]}, {"key": "control-of-the", "type": "clause", "offset": [525, 539]}, {"key": "a-third-party", "type": "clause", "offset": [578, 591]}, {"key": "licensed-technology", "type": "clause", "offset": [629, 648]}, {"key": "the-development", "type": "clause", "offset": [727, 742]}, {"key": "licensed-compound", "type": "definition", "offset": [784, 801]}, {"key": "licensed-products", "type": "clause", "offset": [805, 822]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [823, 841]}, {"key": "prior-to-the-effective-date", "type": "clause", "offset": [848, 875]}], "hash": "1ac5c84d752b9725b7c15f666e41a48b", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih90aGlyZC1wYXJ0eS1jaGFsbGVuZ2VzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"title": "Third Party Challenges", "size": 36, "children": [], "parents": [["representations-and-warranties-certain-covenants", "Representations and Warranties Certain Covenants"], ["records", "Records"], ["access", "Access"], ["inventions-and-patents", "Inventions and Patents"], ["additional-representations-warranties-and-covenants-of-surface", "Additional Representations, Warranties and Covenants of Surface"]], "id": "third-party-challenges", "related": [["no-challenges", "No Challenges", "No Challenges"], ["third-party-proceedings", "Third Party Proceedings", "Third Party Proceedings"], ["challenges", "Challenges", "Challenges"], ["third-party-ip", "Third Party IP", "Third Party IP"], ["defense-of-third-party-claims", "Defense of Third Party Claims", "Defense of Third Party Claims"]], "related_snippets": [], "updated": "2025-07-07T12:36:18+00:00", "also_ask": ["What negotiation leverage does a Third Party Challenges clause provide to each party?", "What essential elements must be included to ensure enforceability of this clause?", "What are the most common risks or loopholes that could undermine this clause?", "How does this clause compare to industry-standard third party challenge provisions?", "What factors do courts consider when determining the validity of a Third Party Challenges clause?"], "drafting_tip": "Specify procedures for handling third-party challenges to clarify responsibilities, define timelines to ensure prompt resolution, and allocate costs to prevent disputes.", "explanation": "The Third Party Challenges clause defines how disputes or claims brought by external parties, rather than the contracting parties themselves, are to be handled under the agreement. Typically, this clause outlines the procedures to follow if a third party alleges that a product, service, or intellectual property involved in the contract infringes on their rights. For example, it may require the party receiving notice of a challenge to promptly inform the other party, and may specify who is responsible for defending against such claims or covering related costs. The core function of this clause is to allocate responsibility and risk between the contracting parties in the event of third-party legal challenges, ensuring that both parties understand their obligations and reducing uncertainty in the face of external disputes."}, "json": true, "cursor": ""}}